REVIEW OF SUBTRIGONAL INJECTIONS IN THE TREATMENT OF DETRUSOR HYPERACTIVITY

被引:0
|
作者
BENNANI, S
机构
关键词
URODYNAMICS; DETRUSOR INSTABILITY; SUB-TRIGONAL INJECTION; PHENOL; ETHANOL;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The treatment of detrusor hyperactivity still constitutes one of the great failures of twenty years urodynamic research, of this disease still requires many studies and research in order to more dearly understand as its mechanisms, and its etiologies and to define a more effective and specific therapy. The cures, suggested at the present time, as preliminaries to this pathology, are bladder anticholinergics, oxybutynin and retraining with or without biofeedback. The treatment for hyperactive bladder refractory to these usual treatments includes sub-trigonal injection of phenol or ethanol which constitutes a simple and effective method, less invasive than the other surgical methods which are generally used. The results of this method are satisfactory, for one year, in 40 % of cases and complications occur for 13 % of patients.This morbidity would decrease if a more rigorous selection of patients were undertaken. Patients previously treated by pelvic radiotherapy or surgery constitute a contraindication to this technique. Similarly, special precautions should be taken in men and when a large amount of these products is injected. Otherwise, it is essential to warn patients of the risks which this technique, involves, particularly urine retention, impotence and fistulas.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 50 条
  • [41] Management of Patients with Detrusor Hyperactivity with Impaired Contractility
    Fan-Ching Hung
    Hann-Chorng Kuo
    Current Bladder Dysfunction Reports, 2023, 18 : 280 - 284
  • [42] Sacral Neuromodulation for detrusor hyperactivity with impaired contractility
    Hennessey, D. B.
    Hoag, N.
    Gani, J.
    BJU INTERNATIONAL, 2017, 120 : 47 - 47
  • [43] SACRAL NEUROMODULATION FOR DETRUSOR HYPERACTIVITY WITH IMPAIRED CONTRACTILITY
    Hennessey, Derek
    Hoag, Nathan
    Gani, Johan
    JOURNAL OF UROLOGY, 2017, 197 (04): : E745 - E746
  • [44] INTRAVESICAL INSTILLATION OF DRUGS IN PATIENTS WITH DETRUSOR HYPERACTIVITY
    EKSTROM, B
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1992, : 1 - +
  • [45] CONTEMPORARY TREATMENT OF DETRUSOR SPHINCTER DYSSYNERGIA: A SYSTEMATIC REVIEW
    Li, Hanhan
    Borchert, Alex
    Atiemo, Humphrey
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S54 - S55
  • [46] Contemporary Treatment of Detrusor Sphincter Dyssynergia: a Systematic Review
    Li H.
    Nahm N.
    Borchert A.
    Wong P.
    Atiemo H.
    Current Bladder Dysfunction Reports, 2018, 13 (4) : 206 - 214
  • [47] RISK OF URINARY TRACT INFECTION AFTER DETRUSOR BOTULINUM TOXIN A INJECTIONS FOR REFRACTORY NEUROGENIC DETRUSOR OVERACTIVITY IN PATIENTS WITH NO ANTIBIOTIC TREATMENT REPLY
    Game, Xavier
    Malavaud, Bernard
    BJU INTERNATIONAL, 2011, 107 (07) : 1165 - 1165
  • [48] Outcomes of Intra-Detrusor Injections of Botulinum Toxin in Patients With Spina Bifida: A Systematic Review
    Hascoet, Juliette
    Manunta, Andrea
    Brochard, Charlene
    Arnaud, Alexis
    Damphousse, Mireille
    Menard, Helene
    Kerdraon, Jacques
    Journel, Hubert
    Bonan, Isabelle
    Odent, Sylvie
    Fremond, Benjamin
    Siproudhis, Laurent
    Game, Xavier
    Peyronnet, Benoit
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (03) : 557 - 564
  • [49] Re: Solifenacin Treatment After Intradetrusor Injections With Botulinum Toxin in Patients With Neurogenic Detrusor Overactivity
    Elliott, Sean P.
    JOURNAL OF UROLOGY, 2023, 209 (01): : 289 - 289
  • [50] Detrusor injections of botulinum neurotoxin type a (BoNT/A) for the treatment of bladder symptoms of multiple sclerosis (MS)
    Kalsi, V.
    Gonzales, G.
    Apostolidis, A.
    Popat, R.
    Elneil, S.
    Dasgupta, P.
    Fowler, C. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 245 - 245